J Fang, MH Alderman - Jama, 2000 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Although many ... Cited by 473 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org RJ Johnson, DH Kang, D Feig, S Kivlighn, J … - Hypertension, 2003 - Am Heart Assoc Hyperuricemia is associated with hypertension, vascular disease, renal disease,
and cardiovascular events. In this report, we review the epidemiologic evidence
and potential mechanisms for this association. We also summarize ... Cited by 401 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org M Mazzali, J Hughes, YG Kim, JA Jefferson, … - Hypertension, 2001 - Am Heart Assoc Abstract—— An elevation in circulating serum uric acid is strongly
associated with the development of hypertension and renal disease, but whether
uric acid has a causal role or whether it simply indicates patients at risk ... Cited by 352 - Related articles - BL Direct - All 5 versions
C Bickel, HJ Rupprecht, S Blankenberg, G … - The American journal of cardiology, 2002 - Elsevier It is a matter of controversy as to whether uric acid is an independent
predictor of mortality in patients with coronary artery disease (CAD) or whether
it represents only an indirect marker of adverse outcome by reflecting the ... Cited by 315 - Related articles - BL Direct - All 6 versions
- ►physiology.org [PDF] M Mazzali, J Kanellis, L Han, L Feng, YY … - American Journal of Physiology- Renal Physiology, 2002 - Am Physiological Soc 44 other HighWire hosted articles, the first 5 are: This article has been cited
by ... [PDF] [Full Text] [Abstract] , July 1, 2009; 58 (7): 1668-1671. Diabetes
P. Hovind, P. Rossing, L. Tarnow, RJ Johnson and H.-H. Parving Diabetes: An ... Cited by 222 - Related articles - BL Direct - All 4 versions
Y Lacourcière, A Belanger, C Godin, JP Halle … - Kidney international, 2000 - nature.com The objectives of this study were to compare the effects of the angiotensin II
receptor blocker, losartan, to those of the angiotensin-converting enzyme
inhibitor, enalapril, on albuminuria and renal function in relationship to ... Cited by 204 - Related articles - BL Direct - All 4 versions
- ►uvt.nl [PDF] LV Franse, M Pahor, MD Bari, RI Shorr, JY … - Journal of hypertension, 2000 - journals.lww.com Sponsorship: The Systolic Hypertension in the Elderly Program (SHEP) was
supported by contracts with the National Heart, Lung, and Blood Institute and
the National Institute on Aging. Drugs were supplied by the Lemmon Co ( ... Cited by 200 - Related articles - BL Direct - All 6 versions
- ►toodoc.com [PDF] LK Niskanen, DE Laaksonen, K Nyyssonen, G … - Archives of Internal Medicine, 2004 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 185 - Related articles - BL Direct - All 9 versions
A Høieggen, MH Alderman, SE Kjeldsen, S … - Kidney international, 2004 - nature.com The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
demonstrated the superiority of a losartan-based regimen over atenolol-based
regimen for reduction of cardiovascular (CV) morbidity and mortality. It ... Cited by 186 - Related articles - BL Direct - All 7 versions
